Pure Global
Singapore HSA registration DE0003652

Eli Lilly HumaPen Ergo II Insulin Delivery Device

Singapore flagSingapore·CLASS C·Eli Lilly and Company·Registered June 14, 2006
Device classification
Device Class
CLASS C
Medical Speciality Area
General Hospital
Registration information
Registration Number
DE0003652
Registration Date
June 14, 2006
Change Notification Approval Date
April 14, 2025
Retention Due Date
August 09, 2025
Product description
Intended to be used for self-injection of insulin. The device is intended for use only with Eli Lilly Humulin or Humalog 3 mL Insulin Cartridges (100 IU/mL) and pen needles which are supplied separately.
Product Owner
Name
Eli Lilly and Company
Short Name
Eli Lilly
Address
Pharmaceutical Delivery Systems, Lilly Corporate Center, Indianapolis, Indiana, 46285, Indianapolis, Indiana, UNITED STATES
Registrant
Name
DKSH SINGAPORE PTE. LTD.
Address
47 JALAN BUROH, #09-01, SINGAPORE 619491
Importer
Name
DKSH SINGAPORE PTE. LTD.
Address
47 JALAN BUROH, #09-01, SINGAPORE 619491
Model information
Model Name(s)
Humapen Ergo II
Model Identifier(s)
MS9557
About this record

Access comprehensive regulatory information for Eli Lilly HumaPen Ergo II Insulin Delivery Device in the Singapore medical device market through Pure Global AI's free database. This CLASS C medical device is registered under HSA registration number DE0003652 and owned by Eli Lilly and Company. The device was registered on June 14, 2006.

This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.

Free DatabasePowered by Pure Global AIHSA Official DataCLASS C